The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on VYGR stock, giving a Buy rating today. Patrick ...

TD Cowen analyst Phil Nadeau has maintained their bullish stance on VYGR stock, giving a Buy rating on November 1. Phil Nadeau’s rating ...

Zacks Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform Unlock potential with Voyager Therapeutics as HC Wainwright ...

Bitcoin’s four-year cycle is partly influenced by the scheduled halving events, which reduce the block reward miners receive ...

LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $9 million in its third quarter. On a per-share basis, the Lexington, Massachusetts-based ...

Voyager Acquisition Corp. focuses on effecting a merger, amalgamation, arrangement, share exchange, asset acquisition, share purchase, reorganization, or any other similar business combination ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. NASA can’t catch a break when it comes to Voyager 1, apparently. That’s because the ...

On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination indicates that Voyager Therapeutics will most likely beat the consensus EPS estimate. Does Earnings Surprise ...